1. Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan- Based Conditioning 
Jonathan E. Brammer, Issa Khouri, Sameh Gaballa, Paolo Anderlini, Ciprian Tomuleasa, Sairah Ahmed, Celina Ledesma, Chitra Hosing, Richard E. Champlin, Stefan O. Ciurea 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages (March 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Outcomes of FM conditioning for advanced lymphoma. (A) Kaplan-Meier estimate of PFS is 54%. (B) PFS for the FM140 group (solid line) was 37% versus 71% in the FM100 group (dashed line), (P = .246). (C) PFS between patients who met protocol eligibility (dotted line) versus though who did not (solid line). Patients who met eligibility had a trend toward improved 2-year PFS (72% versus 29%, P = .074).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions